These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1626124)

  • 1. Nephrotoxicity of thiazoles structurally related to thiabendazole in mice depleted of glutathione by treatment with buthionine sulfoximine.
    Mizutani T; Yoshida K; Ito K
    Res Commun Chem Pathol Pharmacol; 1992 Jan; 75(1):29-38. PubMed ID: 1626124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrotoxicity of thiabendazole in mice depleted of glutathione by treatment with DL-buthionine sulphoximine.
    Mizutani T; Ito K; Nomura H; Nakanishi K
    Food Chem Toxicol; 1990 Mar; 28(3):169-77. PubMed ID: 2344991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex difference in the nephrotoxicity of thiabendazole in mice depleted of glutathione by treatment with DL-buthionine sulphoximine.
    Mizutani T; Yoshida K; Ito K; Kawazoe S
    Food Chem Toxicol; 1992 Mar; 30(3):247-50. PubMed ID: 1618448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrotoxicity of thioformamide, a proximate toxicant of nephrotoxic thiazoles, in mice depleted of glutathione.
    Mizutani T; Suzuki K; Murakami M; Yoshida K; Nakanishi K
    Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):89-101. PubMed ID: 8948017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of thioformamide as a proximate toxicant in the nephrotoxicity of thiabendazole and related thiazoles in glutathione-depleted mice: structure-toxicity and metabolic studies.
    Mizutani T; Yoshida K; Kawazoe S
    Chem Res Toxicol; 1993; 6(2):174-9. PubMed ID: 8477008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of thiabendazole (TBZ) on glutathione (GSH) and GSH related enzymes in mice liver].
    Toda C; Yasui T; Hashizume K; Nagano H
    Yakugaku Zasshi; 2000 Sep; 120(9):787-94. PubMed ID: 11019651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of cisplatin toxicity by buthionine sulfoximine, a glutathione-depleting agent, in mice.
    Ishikawa M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):131-41. PubMed ID: 2326543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatotoxicity of eugenol in mice depleted of glutathione by treatment with DL-buthionine sulfoximine.
    Mizutani T; Satoh K; Nomura H; Nakanishi K
    Res Commun Chem Pathol Pharmacol; 1991 Feb; 71(2):219-30. PubMed ID: 2047567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatotoxicity of eugenol and related compounds in mice depleted of glutathione: structural requirements for toxic potency.
    Mizutani T; Satoh K; Nomura H
    Res Commun Chem Pathol Pharmacol; 1991 Jul; 73(1):87-95. PubMed ID: 1882130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of buthionine sulfoximine on the nephrotoxicity of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (MeCCNU).
    Kramer RA; Schuller HM; Smith AC; Boyd MR
    J Pharmacol Exp Ther; 1985 Aug; 234(2):498-506. PubMed ID: 4020683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of glutathione for cisplatin nephrotoxicity in young and adult rats.
    Appenroth D; Winnefeld K
    Ren Fail; 1993; 15(2):135-9. PubMed ID: 8469780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of enhanced myelotoxicity with buthionine sulfoximine and sulfhydryl-dependent anticancer agents in mice.
    Soble MJ; Dorr RT
    Res Commun Chem Pathol Pharmacol; 1987 Feb; 55(2):161-80. PubMed ID: 3823607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice.
    Smith AC; Liao JT; Page JG; Wientjes MG; Grieshaber CK
    Cancer Res; 1989 Oct; 49(19):5385-91. PubMed ID: 2766304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-Buthionine (S,R) sulfoximine depletes hepatic glutathione but protects against ethanol-induced liver injury.
    Donohue TM; Curry-McCoy TV; Todero SL; White RL; Kharbanda KK; Nanji AA; Osna NA
    Alcohol Clin Exp Res; 2007 Jun; 31(6):1053-60. PubMed ID: 17428293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of phorone and/or buthionine sulfoximine on teratogenicity of 5-fluorouracil in mice.
    Naya M; Mataki Y; Takahira H; Deguchi T; Yasuda M
    Teratology; 1990 Mar; 41(3):275-80. PubMed ID: 2326751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of DL-buthionine-S,R-sulfoximine on the growth of EMT6 and RIF mouse tumors.
    Miller AC; Henderson BW
    J Natl Cancer Inst; 1986 Aug; 77(2):505-10. PubMed ID: 3461211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA; Greene K; Ahmad S; Vistica DT
    Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
    Ono K; Shrieve DC
    J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
    Kisara S; Furusawa S; Murata R; Ogata M; Hikichi N; Takayanagi Y; Sasaki K
    Oncol Res; 1995; 7(3-4):191-200. PubMed ID: 8555653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Styrene-induced hepatotoxicity in mice depleted of glutathione.
    Mizutani T; Irie Y; Nakanishi K
    Res Commun Mol Pathol Pharmacol; 1994 Dec; 86(3):361-74. PubMed ID: 7712112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.